Pharma & life sciences by the numbers

$25.5M

Pharma and life sciences companies spent an average of $25.5 million on litigation in 2020.

58%

of pharma and life sciences companies neglected to pursue judgments in the last year due to the cost of doing so.

$32.7M

The average value of their unenforced judgments was $32.7 million.

We help pharma & life sciences companies maximize returns on legal assets

Corporations from startups to the Fortune 500 use Burford’s solutions to:

  • Remove cost, create budget certainty and reduce risk around complex commercial matters
  • Generate immediate liquidity from pending claims, judgments and awards
  • Leverage high value claims to offset cost of defense matters

Precedent transactions

Why Burford?

Band 1

ranked by Chambers in the US and UK

70%

of clients return to do business again

$4.5B

current investment portfolio